Acadia Healthcare (NASDAQ:ACHC) Hits New 12-Month Low After Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) hit a new 52-week low during mid-day trading on Wednesday after KeyCorp lowered their price target on the stock from $35.00 to $30.00. KeyCorp currently has an overweight rating on the stock. Acadia Healthcare traded as low as $14.94 and last traded at $15.01, with a volume of 3517513 shares trading hands. The stock had previously closed at $15.65.

Several other equities research analysts have also issued reports on ACHC. Cantor Fitzgerald dropped their price target on Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Friday, November 7th. UBS Group lowered their target price on shares of Acadia Healthcare from $31.00 to $28.00 and set a “buy” rating for the company in a research note on Friday, November 7th. Raymond James Financial set a $22.00 target price on shares of Acadia Healthcare in a report on Friday, November 7th. Royal Bank Of Canada decreased their price target on shares of Acadia Healthcare from $28.00 to $22.00 and set an “outperform” rating for the company in a report on Wednesday, November 12th. Finally, Barclays dropped their price objective on shares of Acadia Healthcare from $20.00 to $17.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 6th. Eight investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $32.36.

Institutional Investors Weigh In On Acadia Healthcare

Several large investors have recently modified their holdings of the stock. Caxton Associates LLP acquired a new stake in Acadia Healthcare during the 1st quarter worth about $394,000. Envestnet Portfolio Solutions Inc. boosted its holdings in shares of Acadia Healthcare by 256.4% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 26,053 shares of the company’s stock worth $591,000 after buying an additional 18,742 shares during the period. Oppenheimer Asset Management Inc. increased its position in shares of Acadia Healthcare by 85.1% in the second quarter. Oppenheimer Asset Management Inc. now owns 28,683 shares of the company’s stock worth $651,000 after acquiring an additional 13,188 shares in the last quarter. Janney Montgomery Scott LLC acquired a new stake in shares of Acadia Healthcare during the second quarter valued at approximately $479,000. Finally, PNC Financial Services Group Inc. lifted its position in shares of Acadia Healthcare by 10.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock valued at $202,000 after acquiring an additional 622 shares in the last quarter.

Acadia Healthcare Stock Down 4.1%

The business’s 50 day moving average is $22.41 and its 200 day moving average is $22.51. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The stock has a market cap of $1.38 billion, a price-to-earnings ratio of 9.94, a price-to-earnings-growth ratio of 4.56 and a beta of 0.97.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. During the same quarter in the prior year, the company earned $0.91 earnings per share. The company’s revenue for the quarter was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.